Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

RE: ERP / COGNISION - I am surprised

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
seventhwave Member Profile
 
Followed By 7
Posts 338
Boards Moderated 0
Alias Born 01/07/10
160x600 placeholder
Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease ... GlobeNewswire Inc. - 2/22/2021 7:00:00 AM
Nextech AR (OTCQB: NEXCF) $13 million Deal, Guidance to $50-60 Million, $8.60 Valuation InvestorsHub NewsWire - 2/22/2021 6:18:20 AM
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit GlobeNewswire Inc. - 2/19/2021 7:00:00 AM
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 GlobeNewswire Inc. - 2/18/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:07:35 PM
Nextech AR (OTCQB: NEXCF) 2021 Guidance $50-60 Million Closes 2020 with $20 million. InvestorsHub NewsWire - 2/12/2021 6:26:34 AM
Anavex Life Sciences EPS in-line Seeking Alpha - 2/11/2021 7:22:45 AM
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook GlobeNewswire Inc. - 2/11/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2... GlobeNewswire Inc. - 2/8/2021 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2021 3:17:03 PM
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People wit... GlobeNewswire Inc. - 1/11/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference GlobeNewswire Inc. - 1/6/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:28:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:26:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:25:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:23:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:20:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/28/2020 5:29:22 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/28/2020 5:28:26 PM
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates GlobeNewswire Inc. - 12/28/2020 7:00:00 AM
Biotech Report; Upcoming FDA Reviews and Promising Pipelines InvestorsHub NewsWire - 12/22/2020 8:20:00 AM
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020 GlobeNewswire Inc. - 12/22/2020 7:00:00 AM
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thal... GlobeNewswire Inc. - 12/21/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 7:09:21 AM
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. P... GlobeNewswire Inc. - 12/15/2020 7:00:00 AM
seventhwave   Saturday, 07/27/19 05:58:54 PM
Re: None
Post # of 301310 
RE: ERP / COGNISION - I am surprised people here are wondering how Anavex might be involved with one comment saying, "they probably just joined in."
Cannot be further from the truth IMVHO.
Anavex CHOSE Neuronetrix for its A2-73 P2a trial for Alzh. (see Nov. 7,2014 press release). Their COGNISION system likely adapted symbiotically while working out a solution for Anavex - any lab grown AI system needs a real world application to mould itself into a commercially viable solution.

Now how on earth would obscure little Neuronetrix even start to cobble together a consortium of heavy hitters in neuro-space let alone have them sign them up for a standardization process for the future?

The key is successful VALIDATION of COGNISION in a trial to influence its outcome in an complex multifactorial indication that has seen ZERO trial success for ages. Needless to say it's required the help of influencers like Hampel, French and Anavex's other stellar SAB members, but they have all needed to sprinkle the SPICE(Dunes) of convincing trial outcomes (so far in their possession) to make heads turn.

So make no mistake - Anavex is very much driving this through its influencers in the field.

Analogy: Here in SoCal, we've had quite a few tremblers lately (as high as a shallow 7) and it's generated plenty of talk of "the big one" and also of the yellowstone caldera. A big one is always preceded by an increasing frequency and magnitude of quakes and I cannot help but remark how similar this ERP consortium formation is as one small step that heralds the big leap for mankind with AVXL's A2-73 in Alzheimers, a little more than a year away.

PS: BIIB is so 20th century.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences